Remarkably, a large fraction of the VEGF-B overexpressing tumours, 56% compared to 16% in the control group, did not grow but retained their initial size during the study period, suggesting that VEGF-B overexpression repress oncogenic transformation. The gene discussed is VEGFB; the disease is neoplasm.